Question: What is the risk of returning to work in a major hospital after receiving anti-CD20 therapy?
We do not have much information to guide us at present but here is what we know:
Generally, I recommend that patients with MS on Ocrevus who work in healthcare get transferred to duties with decreased patient interaction, if they are young and have no other risk factors for severe COVID-19 infection. If a person has multiple known risk factors in addition to receiving treatment with COVID 19, I recommend a leave of absence from work until there is a steady decline in cases to the health facility for over 2 weeks and then allow a return to work initially to duties with decreased patient interaction.
In all cases workers should follow social distancing rules with adequate PPE and frequent cleaning of hands and equipment.
I hope this helps
Revere P (Rip) Kinkel, MD
Professor of Clinical Neurosciences
Director of the Multiple Sclerosis Program
Clinical Neurosciences Director
University of California San Diego
PLEASE NOTE: This information/opinions on this site should be used as an information source only. This information does not create any patient-HCP relationship, and should not be used as a substitute for professional diagnosis and treatment. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition.